These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 36418694)
1. Characterization of the Expression and Role of Histone Acetylation and Deacetylation in Dental Pulp Cells. Yamauchi Y; Duncan HF Methods Mol Biol; 2023; 2588():279-293. PubMed ID: 36418694 [TBL] [Abstract][Full Text] [Related]
2. Dynamic Alterations in Acetylation and Modulation of Histone Deacetylase Expression Evident in the Dentine-Pulp Complex during Dentinogenesis. Yamauchi Y; Shimizu E; Duncan HF Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928274 [TBL] [Abstract][Full Text] [Related]
3. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation. Hutt DM; Roth DM; Marchal C; Bouchecareilh M Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814 [TBL] [Abstract][Full Text] [Related]
4. HDACs and HDAC Inhibitors in Cancer Development and Therapy. Li Y; Seto E Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases as targets in autoimmune and autoinflammatory diseases. Hamminger P; Rica R; Ellmeier W Adv Immunol; 2020; 147():1-59. PubMed ID: 32981634 [TBL] [Abstract][Full Text] [Related]
6. The emerging roles of HDACs and their therapeutic implications in cancer. Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787 [TBL] [Abstract][Full Text] [Related]
7. Functional Analysis of HDACs in Tumorigenesis. Hadley M; Noonepalle S; Banik D; Villagra A Methods Mol Biol; 2019; 1983():279-307. PubMed ID: 31087305 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum). Kirfel P; Skaljac M; Grotmann J; Kessel T; Seip M; Michaelis K; Vilcinskas A Arch Insect Biochem Physiol; 2020 Mar; 103(3):e21614. PubMed ID: 31498475 [TBL] [Abstract][Full Text] [Related]
9. Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke. Xu Y; Wang Q; Chen J; Ma Y; Liu X Dis Markers; 2020; 2020():8820803. PubMed ID: 32963637 [TBL] [Abstract][Full Text] [Related]
10. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692 [TBL] [Abstract][Full Text] [Related]
11. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents. Wahi A; Jain P; Sinhari A; Jadhav HR Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):675-702. PubMed ID: 37615708 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. Duncan HF; Smith AJ; Fleming GJ; Cooper PR J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071 [TBL] [Abstract][Full Text] [Related]
13. HDACi: cellular effects, opportunities for restorative dentistry. Duncan HF; Smith AJ; Fleming GJ; Cooper PR J Dent Res; 2011 Dec; 90(12):1377-88. PubMed ID: 21536971 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators. Rafehi H; Karagiannis TC; El-Osta A Curr Top Med Chem; 2017; 17(14):1611-1622. PubMed ID: 27823568 [TBL] [Abstract][Full Text] [Related]
15. Role of Histone Deacetylases in the Pathogenesis of Salivary Gland Tumors and Therapeutic Targeting Options. Manou M; Kanakoglou DS; Loupis T; Vrachnos DM; Theocharis S; Papavassiliou AG; Piperi C Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373187 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy. Ramaiah MJ; Tangutur AD; Manyam RR Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660 [TBL] [Abstract][Full Text] [Related]
17. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot. Beyer M; Kiweler N; Mahboobi S; Krämer OH Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834 [TBL] [Abstract][Full Text] [Related]
18. The application of histone deacetylases inhibitors in glioblastoma. Chen R; Zhang M; Zhou Y; Guo W; Yi M; Zhang Z; Ding Y; Wang Y J Exp Clin Cancer Res; 2020 Jul; 39(1):138. PubMed ID: 32682428 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133 [TBL] [Abstract][Full Text] [Related]
20. A translational perspective on histone acetylation modulators in psychiatric disorders. Ganguly S; Seth S Psychopharmacology (Berl); 2018 Jul; 235(7):1867-1873. PubMed ID: 29915963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]